The Role of the Incretin Hormones GIP and GLP-1 in the Pathogenesis of Type 2 Diabetes

被引：0

作者：

Meier, J. J. ^{[1
]}

机构：

[1] Klinikum Ruhr Univ Bochum, St Josef Hosp, Med Klin 1, D-44791 Bochum, Germany

来源：

DIABETOLOGIE UND STOFFWECHSEL | 2009年 / 4卷 / 05期

关键词：

GASTRIC-INHIBITORY POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE-1; DEPENDENT INSULINOTROPIC POLYPEPTIDE; 1ST-DEGREE RELATIVES; ORAL GLUCOSE; RECEPTOR EXPRESSION; 7-36; AMIDE; SECRETION; PLASMA; HYPERGLYCEMIA;

D O I：

10.1055/s-0029-1224610

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The incretin effect, i.e. the postprandial augmentation of insulin secretion by gastrointestinal hormones, mediates similar to 50-70% of the meal-related increments in insulin secretion in healthy individuals. In contrast, the incretin effect is almost completely absent in patients with type 2 diabetes. The impaired incretin effect in type 2 diabetes has been mainly attributed to the reduced insulinotropic activity of GIP, whereas the actions of GLP-1 are largely preserved. Furthermore, a diminished secretion of GLP-1 has been suggested to contribute to the impaired incretin effect in type 2 diabetes, but this finding has not been confirmed in the majority of studies. This article aims to compare the secretion and action of the incretins GIP and GLP-1 between patients with type 2 diabetes and healthy individuals. In addition, the importance of alterations in the entero-insular axis for the pathogenesis of type 2 diabetes will be discussed.

引用

页码：295 / 300

页数：6

共 50 条

[1] Immunoassays for the incretin hormones GIP and GLP-1
Deacon, Carolyn F.
Holst, Jens J.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 23 (04) : 425 - 432
[2] GIP and GLP-1, the two incretin hormones: Similarities and differences
Seino, Yutaka
Fukushima, Mitsuo
Yabe, Daisuke
JOURNAL OF DIABETES INVESTIGATION, 2010, 1 (1-2): : 8 - 23
[3] Mechanisms underlying the rapid degradation and elimination of the incretin hormones GLP-1 and GIP
Mentlein, Rolf
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 23 (04) : 443 - 452
[4] The incretin system in healthy humans: The role of GIP and GLP-1
Hoist, Jens Juul
METABOLISM-CLINICAL AND EXPERIMENTAL, 2019, 96 : 46 - 55
[5] The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes
Lund, Asger
Vilsboll, Tina
Bagger, Jonatan I.
Holst, Jens J.
Knop, Filip K.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2011, 300 (06): : E1038 - E1046
[6] Incretin effect: GLP-1, GIP, DPP4
Kazakos, Kyriakos
DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 93 : S32 - S36
[7] From the discovery of incretin hormones to GIP / GLP-1 / glucagon double and triple agonists
Phan, Franck
Bertrand, Romane
Amouyal, Chloe
Andreelli, Fabrizio
M S-MEDECINE SCIENCES, 2024, 40 (11): : 837 - 847
[8] The contribution of incretin hormones to the pathogenesis of type 2 diabetes
Meier, Juris J.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 23 (04) : 433 - 441
[9] The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials
Min, Thinzar
Bain, Stephen C.
DIABETES THERAPY, 2021, 12 (01) : 143 - 157
[10] Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and β cell preservation
Yabe, Daisuke
Seino, Yutaka
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2011, 107 (02) : 248 - 256

← 1 2 3 4 5 →